Science|Business Database: Coronavirus Funding Opportunities

Strengthening local and national healthcare infrastructure including funding of additional medical personnel, sourcing of medicines and medical equipment, Establishing digital platforms for COVID-19 related data collection, remote delivery of heal

Any aspect of coronavirus research. Applicants may request up to 300,000 francs for projects lasting up to 24 months. Bigger grants are conceivable, provided the applicant has good reasons for requesting a higher amount.

Support for researchers from four partner universities in Switzerland on diagnostics, human immune response, medical interventions and disease management.

Research must address the prevention and mitigation of the impact of pandemics on people in Africa. A focus on the current COVID-19 crisis in encouraged.

Researcher required to provide insight into how the Global Compact for Migration was used in the COVID-19 crisis, what lessons can be learnt from it, and what implications the pandemic may have for the future of the agreement.

Projects must advance the understanding of COVID-19 and the development of vaccines, therapeutics, and diagnostics. Multidisciplinary collaborations and use of international research networks are encouraged.

Funding for projects exploring the clinical course of COVID-19, diagnostic and therapeutic challenges and pathogenic mechanisms in patients with rheumatic musculoskeletal diseases.

Funding for collaborative projects between researchers from Switzerland and China, Japan, South Korea or the ASEAN Region in any discipline.

Exploratory, basic, and clinical research should address but is not limited to COVID-19 in patients at different pregnancy stages, and its impact on ongoing fertility care, gametes and embryos from patients exposed to SARS-CoV-2.